CSF Mitochondrial DNA Indicates Body Composition and Energy Metabolism in Parkinson’s Disease.
Objective: This study aimed to elucidate the associations between cerebrospinal fluid (CSF) cell-free mitochondrial DNA (cf-mtDNA) levels and body composition, nutritional status, and metabolic biomarkers…Characterization of DBS-induced Speech Improvements in a German PD Cohort
Objective: To investigate speech changes induced by subthalamic deep brain stimulation (DBS) in persons with Parkinson’s disease (pwPD). Background: Dysarthria is a common debilitating motor…Digital measurement of ocular microtremor in Parkinson’s Disease: Analytical and clinical validation
Objective: This pilot study examined the analytical and clinical validation of OMT measurement via the iTremor ONE device in PwPD. Background: Ocular microtremor (OMT) is…Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease
Objective: To assess and compare personality profiles and psychiatric symptoms in de-novo clinically-established body-first and brain-first PD. Background: Body-first and brain-first have recently been proposed…Exploring Uncertainties and Fears of People with Parkinson Disease
Objective: To assess the burden of uncertainties, hopes, and fears of people with Parkinson disease (PwP). Background: Parkinson disease (PD) is associated with significant psychosocial…Neurophysiological research on inhibitory processes in Parkinson’s disease
Objective: To explore neural mechanisms of inhibitory control, specifically differentiating reactive from prepared inhibitory processes, by synthesizing recent intracranial EEG (iEEG) studies and neurophysiological research…Episodic Simulation in Parkinson’s Disease (PD)
Objective: Characterize episodic simulation capabilities in non-depressed, non-amnestic patients with PD compared to healthy controls using autobiographical interviewing techniques. Background: Cognitive decline in PD occurs…Orthostatic Hypotension and Acute Cognitive Dysfunction in Parkinson’s Disease: Insights from fNIRS
Objective: To define cerebral oxygenation changes during positional cognitive testing in Parkinson’s disease (PD), comparing those with orthostatic hypotension (OH+) to those without (OH-). Background:…Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.
Objective: To identify the clinical correlation between neurocognitive functioning and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that measures depression…Association Between Pesticide Exposure and Clinical Outcomes in Parkinson’s Disease: A Propensity-Matched Cohort Study
Objective: To evaluate the clinical outcomes associated with pesticide exposure in Parkinson’s disease (PD) participants in the Canadian Open Parkinson Network (COPN)(1). Background: Pesticide exposure…
- « Previous Page
- 1
- …
- 96
- 97
- 98
- 99
- 100
- …
- 181
- Next Page »